Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
…, T Imazato, N Iwamoto, K Fujikawa, T Aramaki… - Rheumatology …, 2011 - Springer
We investigated the effects of anti-IL-6 receptor antibody, tocilizumab (TCZ), on lipid metabolism.
Nineteen patients with rheumatoid arthritis (RA), entered in clinical case–control study …
Nineteen patients with rheumatoid arthritis (RA), entered in clinical case–control study …
A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic …
…, N Iwamoto, K Fujikawa, T Aramaki… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To evaluate whether magnetic resonance imaging (MRI) of the wrists and finger
joints and an analysis of serologic autoantibodies are clinically meaningful for the subsequent …
joints and an analysis of serologic autoantibodies are clinically meaningful for the subsequent …
Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line.
…, N Iwanaga, K Fujikawa, T Aramaki… - The Journal of …, 2007 - jrheum.org
OBJECTIVE: We investigated expression of toll-like receptor (TLR) in labial salivary glands
of patients with Sjögren's syndrome (SS) and functional TLR expression in the cultured …
of patients with Sjögren's syndrome (SS) and functional TLR expression in the cultured …
A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis
T Aramaki, H Ida, Y Izumi, K Fujikawa… - Modern …, 2009 - Taylor & Francis
To elucidate the characterization of peripheral natural killer (NK) cells in patients with
rheumatoid arthritis (RA), we investigated the NK cell activity, the expression of NK cell activating …
rheumatoid arthritis (RA), we investigated the NK cell activity, the expression of NK cell activating …
Clinical outcomes in the first year of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome
…, F Tanaka, Y Kawabe, T Aramaki… - Modern …, 2017 - academic.oup.com
Objective: We investigated clinical outcomes in patients with remitting seronegative
symmetrical synovitis with pitting edema (RS3PE) syndrome. Methods: This is a retrospective …
symmetrical synovitis with pitting edema (RS3PE) syndrome. Methods: This is a retrospective …
[HTML][HTML] Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
…, S Kawashiri, K Fujikawa, T Igawa, T Aramaki… - Arthritis Research & …, 2021 - Springer
Objective To compare the efficacy and safety of tofacitinib and baricitinib in patients with RA
in a real-world setting. Methods A total of 242 patients with RA who were treated with …
in a real-world setting. Methods A total of 242 patients with RA who were treated with …
Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum …
…, N Iwamoto, K Fujikawa, T Aramaki… - The Journal of …, 2009 - jrheum.org
Objective. Chemokine ligand 20 (CCL20) is a selective ligand for chemokine receptor 6 (CCR6).
We investigated, both in vitro and in vivo, whether CCL20 is critically involved in the …
We investigated, both in vitro and in vivo, whether CCL20 is critically involved in the …
High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome
…, H Nakamura, T Tsukada, T Aramaki… - Modern …, 2012 - Taylor & Francis
Recently, it was reported that remitting seronegative symmetrical synovitis with pitting edema
(RS3PE) syndrome could be complicated with solid tumors. In a retrospective, multicenter …
(RS3PE) syndrome could be complicated with solid tumors. In a retrospective, multicenter …
[HTML][HTML] Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis
…, A Nishino, Y Horai, T Koga, S Kawashiri, T Aramaki… - PLoS …, 2017 - journals.plos.org
Objective We evaluated the efficacy and safety of tofacitinib in patients with rheumatoid arthritis
(RA) in a real-world setting. Methods Seventy consecutive patients, for whom tofacitinib …
(RA) in a real-world setting. Methods Seventy consecutive patients, for whom tofacitinib …
[HTML][HTML] Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving …
…, S Honda, Y Horai, R Watanabe, H Okuno, T Aramaki… - PLoS …, 2017 - journals.plos.org
Objectives To determine prognostic factors of clinically relevant radiographic progression (CRRP)
in patients with rheumatoid arthritis (RA) achieving remission or low disease activity (…
in patients with rheumatoid arthritis (RA) achieving remission or low disease activity (…